A growing platform of AI-assisted, reviewer-gated clinical decision-support modules — built by clinicians, audited at every step, published only when a named reviewer signs off.
Built for ENT clinicians, audiology and neurology trainees, and vestibular therapists.
A 65-year-old man presents with continuous spinning vertigo for 6 hours and persistent horizontal nystagmus that beats to the right. What do the three HINTS findings suggest?
Pick one option in each row to see the interpretation.
Today in ENT · 20 Sept 2026
6 peer-reviewed articles from 44 whitelisted ENT journals, AI-scored for clinical relevance and summarised for practising clinicians.
Vagus nerve stimulation for drug-resistant epilepsy consistently reduced maximum phonation time by ~9 seconds and significantly worsened Voice Handicap Index scores compared to controls, alongside increased jitter, shimmer, and perceptual voice deterioration. Routine voice monitoring should be incorporated into long-term management of VNS patients.
Laryngopharyngeal reflux was present in up to 58% of adults with Eustachian tube dysfunction and 77% with otitis media with effusion, with pepsin detected in 40% of middle ear effusions, suggesting a probable association; however, methodological heterogeneity across 20 studies prevents causal conclusions.
In OSCC, tumor-associated macrophages form functionally diverse, spatially organized populations driven by hypoxia, lactate, cytokines, cancer-associated fibroblasts, and microbial signals rather than a simple M1/M2 dichotomy. CD163- and CD206-high macrophage infiltration correlates with adverse clinicopathologic features, and preclinical TAM-targeting strategies reduced tumor-promoting activity but require prospective validation before clinical use.
Molecularly targeted therapies for RAI-refractory differentiated thyroid cancer in Japan have shifted from histology-based MKI selection toward genotype-directed treatment using BRAF/MEK, RET, and TRK inhibitors, though mutual exclusivity of driver alterations limits each agent's eligible population. Optimising sequencing of MKIs and targeted agents alongside comprehensive genomic profiling is now central to improving outcomes.
Upcoming events · refreshed 13 Sept 2026
12 otorhinolaryngology conferences, workshops and cadaver courses in the next twelve months — international, national and regional, curated weekly by AI from official society sites.
Leading francophone scientific congress gathering 2,500+ professionals with focus on AI, innovation, and hearing health at CNIT La Défense.
Premier annual gathering for otolaryngology with 300+ sessions and CME credits available through OTO Logic platform.
International platform for otology and neurotology research dedicated to healthy ears for all mankind, featuring Politzer Prize.
Leading Middle East ENT conference bringing together GCC societies and AAO-HNS partnership for cochlear implant advancement.
A clinician-facing decision-support tool for Otolaryngology, derived from the structure of *Decision Making in Otolaryngology* with every node's content freshly synthesised from peer-reviewed literature and reviewer-approved before going live (per ADR 0005). v1 ships Sudden Sensorineural Hearing Loss end-to-end; further chapters expand from there using the same pipeline.
SSNHL · v1 chapter · pipeline 56%
Chapters
Vertigo decision support — coming after the ORL module validates the pipeline.
Nasal allergy decision support — pending Rhino-AI compatibility audit (ADR 0003).
Disclaimer
For educational purposes only. Not for clinical use. This platform is an instructional resource intended to support learning about clinical decision-making and the interpretation of investigations. Clinicians remain completely responsible for the interpretation of findings, the formulation of a differential diagnosis, and any clinical decision. Nothing in this application replaces individualized assessment, hands-on training, expert consultation, or established practice guidelines.
Not for profit effort by
Supporting organisations
